GlassScriptPhysician profile
Amy H Lim
NPI 1639514979
$2,177.47
in general payments reported to CMS, 2019-2025
23 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $16.19 · 2021: $55.56 · 2022: $96.74 · 2023: $253 · 2024: $1,236 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $906 · Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $906.20 |
| Food and Beverage | $814.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,124.75 | 2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $244.50 | 2019 | |
| Edap Technomed INC | $98.32 | 2023 | |
| Boston Scientific Corporation | $90.41 | 2021-2025 | Greenlight Xps, Spaceoar Vue System - 10ml, Lithovue Elite |
| Coloplast Corp | $79.90 | 2021-2025 | Self-Cath |
| Merck Sharp & Dohme LLC | $66.43 | 2019-2025 | Keytruda |
| Bluewind Medical | $60.00 | 2025 | Revi |
| Ethicon US, LLC | $59.25 | 2024 | Stratafix |
| 180 Medical, INC. | $56.07 | 2022-2023 | Cure Catheter |
| Abbvie INC. | $47.52 | 2022-2025 | |
| Urogen Pharma, INC. | $36.33 | 2022-2023 | |
| C. R. Bard, INC. & Subsidiaries | $28.87 | 2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $24.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.50 | 2025 | |
| Innovation Technologies INC | $23.33 | 2024 | Irrisept |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $16.86 | 2023 | Urolift |
| Endo Pharmaceuticals INC. | $16.19 | 2020 | |
| Recordati_rare_diseases_inc. | $16.02 | 2025 | Panhematin |
| Sumitomo Pharma America, INC. | $15.37 | 2025 | Orgovyx |
| Profound Medical Corp. | $15.37 | 2022 | |
| Cook Medical LLC | $14.73 | 2025 | S~Curve |
| Axonics, INC. | $14.35 | 2023 | Axonics, Bulkamid |
| Travere Therapeutics, INC. | $3.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.